BackBiosig Technologies Overview

Biosig Technologies Receivables

Biosig Technologies's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
100.00% YoYΔ $-109000.00 vs prior year quarter

Peer average

Loading

Biosig Technologies Receivables History

Loading

Biosig Technologies vs. peers: Receivables Comparison

Loading

Biosig Technologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biosig Technologies (BSGM) FAQ

As of the most recent data (March 2026), BSGM shows a receivables of $0. That compares with $110K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BSGM's receivables is now $0 (was $110K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biosig Technologies is outperforming or lagging.

Tracking BSGM's receivables over time shows whether Biosig Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $110K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Biosig Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Biosig Technologies's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.